Business Details
30 Years
experience
Your Trusted Partner for Consumer Healthcare Consulting Solutions
Established in 1996 by Jeremy Kelly and Jason Kalik, our firm specialises in Consumer Healthcare consulting, leveraging over 30 years of combined industry experience from senior roles at global corporations like GlaxoSmithKline and Pfizer. We have advised more than 50 multinational and local companies across diverse markets including North America, China, and the EU, focusing on strategic decision-making and data-driven analytics. Our proprietary Evidence Base methodology provides automated tools to optimise management decisions, utilising clients' existing data investments for enhanced performance monitoring and reporting. With expertise in brand acquisition, portfolio analysis, and geographic strategic planning, we deliver tailored solutions that integrate Western and local market insights. Our team's deep understanding of key data sources, including sales audit providers and primary research firms, ensures comprehensive analytics aligned with global best practices.Through partnerships like China Deal Flow with TPP Healthcare, we address complex market entry challenges in high-growth regions. Our commitment to transparency and client-centric approaches has solidified our reputation as a trusted advisor in the healthcare sector. We prioritise actionable insights that streamline processes, reduce operational strain, and deliver measurable value to stakeholders. Our services span from R&D resource planning to anti-trust analysis, supporting clients at every stage of their business lifecycle. By combining decades of experience with innovative tools, we empower companies to navigate the evolving healthcare landscape with confidence.
Services
Strategic Planning
Market Analysis
Brand Acquisition
Portfolio Analysis
Performance Monitoring
R&D Resource Planning
Anti-Trust Analysis
Geographic Expansion
Data Analytics
Business Development
Details
- Year established: 1996
Highlights and features
- We have over 30 years of combined experience in Consumer Healthcare from senior industry roles.
- Our Evidence Base tools provide automated analytics for faster, more accurate decision-making.
- We operate globally, with expertise in markets including China, North America, and Europe.
- Our team has advised over 50 multinational and local healthcare companies.
- We partner with local experts to deliver tailored market entry strategies in high-growth regions.
Services
Strategic Planning
We develop tailored strategic plans for Consumer Healthcare companies, focusing on geographic expansion, portfolio optimisation, and market entry. Our approach combines global best practices with local market insights to ensure actionable, data-driven strategies. Clients benefit from our 30+ years of industry experience and proprietary analytical tools.
Market Analysis
Our market analysis services leverage sales audit data and primary research to identify trends, competitive landscapes, and growth opportunities. Using tools like Evidence Base, we provide actionable insights for brand positioning and business development in diverse regions including China and Latin America.
Brand Acquisition
We guide clients through the brand acquisition process, from target identification to due diligence and valuation. Our expertise in regulatory feasibility and deal structuring ensures successful mergers and acquisitions in complex markets like China's high-growth Consumer Healthcare sector.
Data Analytics
Our Evidence Base platform transforms raw data into strategic insights, offering automated reporting and performance monitoring. This system helps clients optimise resource allocation and decision-making across global, regional, and country-level operations.
Business Development
We facilitate business development through partnerships, licensing agreements, and market entry strategies. Our China Deal Flow initiative, in collaboration with TPP Healthcare, specialises in connecting companies with local partners and M&A opportunities in Asia.
People
Jeremy Kelly
Co-Founder & Director
Co-founder with 30+ years in Consumer Healthcare, previously held senior roles at GlaxoSmithKline and Pfizer. Specialises in strategic planning and data-driven decision-making for global healthcare firms.
Jason Kalik
Co-Founder & Director
Co-founder bringing extensive experience in business development and market analysis from senior positions at Novartis and Reckitt Benckiser. Focuses on cross-border partnerships and analytics for healthcare companies.
Questions
What areas of healthcare do you specialise in?
We focus on Consumer Healthcare (CHC), covering categories like analgesics, dermatology, vitamins, and smoking cessation across global markets.
How do you help companies entering the Chinese market?
Through China Deal Flow, we provide local insights, partner identification, and regulatory guidance to navigate China's complex healthcare landscape.
What tools do you use for data analysis?
Our proprietary Evidence Base™ platform automates analytics and reporting, integrating clients' existing data for strategic decision-making.
Can you assist with brand acquisitions?
Yes, we support the full M&A lifecycle, including target screening, due diligence, valuation, and post-merger integration strategies.
Do you offer free consultations?
Yes, we provide a free initial consultation to demonstrate how our tools and expertise can enhance your data-driven decision-making.
